LEARN · FIELD NOTES
Learn
Practical guides from the bench and the terminal.
ADC linker chemistryDesignNEW→ADC payload classesDesignNEW→Affinity maturationDesignIN PROGRESSAntibody discoveryDesignIN PROGRESSAntibody numbering and CDR definitionsDesignNEW→Antibody structure predictionDesignNEW→Binding affinity predictionDesignIN PROGRESSBinding site analysisDesignIN PROGRESSBispecific and multispecific formatsDesignNEW→Co-folding and its limitsDesignNEW→Cyclic and stapled peptidesDesignNEW→DevelopabilityDesignIN PROGRESSDevelopability liabilities in CDRsDesignNEW→Diffusion models for binder designDesignNEW→Epitope selectionDesignNEW→Extending peptide half-lifeDesignNEW→Homology modelingDesignIN PROGRESSHumanizationDesignNEW→In silico screeningDesignIN PROGRESSMolecular dynamics for binder designDesignNEW→Open-source protein design toolsDesignNEW→Peptide designDesignIN PROGRESSPhage and yeast displayDesignNEW→Protein language modelsDesignNEW→Reformatting between VHH, scFv, Fab and IgGDesignNEW→Sequence-function analysisDesignIN PROGRESSSite-specific conjugationDesignNEW→Structure-guided designDesignIN PROGRESSVHH and nanobody designDesignNEW→Variant library designDesignIN PROGRESSAntibody purificationBuildNEW→Antigen quality controlBuildNEW→CHO transient expressionBuildNEW→Endotoxin in cell assaysBuildNEW→Enzymatic conjugationBuildNEW→Gene synthesis and cloning strategyBuildNEW→HEK cell expressionBuildNEW→Peptide purification by RP-HPLCBuildNEW→Protein storage and handlingBuildNEW→Small-scale expression screeningBuildNEW→Solid-phase peptide synthesisBuildNEW→Titer and integrity QCBuildNEW→Affinity and avidityAssayNEW→Antigen biotinylationAssayNEW→Assay developmentAssayIN PROGRESSBlocking assaysAssayNEW→Cell binding by flow cytometryAssayNEW→Cytotoxicity and cell-killing assaysAssayNEW→Dose-response titration and EC50AssayNEW→ELISAAssayNEW→Epitope binningAssayNEW→Internalization assaysAssayNEW→Plate layout and controlsAssayNEW→SPR kineticsAssayNEW→Species cross-reactivityAssayNEW→Specificity and polyspecificityAssayNEW→AmyloidsCNS and aggregationNEW→Brain exposure for antibodiesCNS and aggregationNEW→Conformation-selective antibodiesCNS and aggregationNEW→Preparing recombinant tau and alpha-synucleinCNS and aggregationNEW→Protein aggregationCNS and aggregationNEW→Seeding assays in HEK cellsCNS and aggregationNEW→Staining aggregates in tissueCNS and aggregationNEW→Tau, alpha-synuclein and TDP-43 as antibody targetsCNS and aggregationNEW→Thioflavin T kineticsCNS and aggregationNEW→Bioconjugation for ADCsScale-upNEW→Conjugation process developmentScale-upNEW→Formulation and buffer screeningScale-upNEW→Maleimide conjugate stabilityScale-upNEW→Protein stabilityScale-upIN PROGRESSReducing interchain disulfidesScale-upNEW→SEC-HPLC and aggregation QCScale-upNEW→Scaling peptide manufactureScale-upNEW→Thermal shift assaysScale-upNEW→ADC aggregation and hydrophobicityAnalyticalNEW→Analytical release testing for peptidesAnalyticalNEW→Bioburden testingAnalyticalNEW→Forced degradationAnalyticalNEW→Freeze-thaw stabilityAnalyticalNEW→HPLCAnalyticalIN PROGRESSMass spectrometry for proteinsAnalyticalNEW→Measuring drug-to-antibody ratioAnalyticalNEW→Peptide stability and degradationAnalyticalNEW→Plasma stabilityAnalyticalNEW→Quantifying free thiolsAnalyticalNEW→Shelf lifeAnalyticalIN PROGRESSStability studiesAnalyticalIN PROGRESSBriefing a CROStrategyNEW→Discovery program strategyStrategyIN PROGRESSDue diligenceStrategyIN PROGRESSTeam trainingStrategyIN PROGRESSTechnology assessmentStrategyIN PROGRESSTroubleshootingStrategyIN PROGRESS
No guide matches that.